Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Antiviral Res. 2015 Jun 12;121:16–23. doi: 10.1016/j.antiviral.2015.06.005

Figure 6. Analysis of VZV infection.

Figure 6

(a) ARPE-19 cell lysates were assayed for luciferase activity following infection with VZV-ORF63fluc in the presence or absence of drugs for 48hpi. LCPS: luciferase counts per second. *p≤0.013. (b) Cytotoxicity of the compounds in the absence of VZV in ARPE-19 cells. (c) Efficacy of 30N12, 16F19, and 4F17 at different concentrations; with the luciferase assay performed at 48hpi. The data represent an average of three independent experiments. Error bars represent standard deviations.